Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications

Pharmacology & Therapeutics
S K Wattanapitayakul, J A Bauer

Abstract

Despite some recent declines, cardiovascular disease (CVD) remains the major cause of death in the United States and worldwide. Most recent advances in the treatment of CVD states have been produced by inhibition of mechanisms involved in disease progress. Many studies conducted in the last decade have illustrated increased biological oxidative pathways during CVD in animals and humans. Thus, increased production of reactive oxygen species may be a unifying mechanism in CVD progression, and antioxidants may have therapeutic value in this setting. In this review we address the following questions: Do oxidative mechanisms play a role in CVD? Where do the oxidants come from? What are the relevant oxidative events? What are the therapeutic implications?

References

Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·L S TeradaJ E Repine
Jan 1, 1990·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A BochenekH Gryzbek
Jan 1, 1982·Annals of the New York Academy of Sciences·L J Machlin, E Gabriel
Jan 1, 1995·Journal of Cardiovascular Pharmacology·P CastelliE Riva
Oct 12, 1994·Molecular and Cellular Biochemistry·M KanekoN Yamazaki
Apr 14, 1994·The New England Journal of Medicine·UNKNOWN Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
Dec 22, 1993·Molecular and Cellular Biochemistry·P K SingalT P Thomas
May 20, 1993·The New England Journal of Medicine·M J StampferW C Willett
May 20, 1993·The New England Journal of Medicine·E B RimmW C Willett
Jul 1, 1995·International Journal of Cardiology·S M WildhirtR J Bing
May 2, 1996·The New England Journal of Medicine·G S OmennS Hammar
May 2, 1996·The New England Journal of Medicine·L H KushiR M Bostick
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·J LotemL Sachs
Jul 1, 1996·Chemical Research in Toxicology·J S Beckman
Jan 1, 1996·Free Radical Biology & Medicine·Y Sun, L W Oberley
Jan 1, 1996·Journal of Cardiovascular Pharmacology·A Grynberg, L Demaison
Oct 25, 1996·Atherosclerosis·S L KillionK E McIntyre
Jan 1, 1997·Free Radical Biology & Medicine·Y J SuzukiA Sevanian
Mar 1, 1996·Journal of Molecular and Cellular Cardiology·C KupattE Gerlach
Aug 7, 1997·The New England Journal of Medicine·M N DiazJ F Keaney
Aug 15, 1997·The Journal of Biological Chemistry·B S Berlett, E R Stadtman
Sep 23, 1997·Journal of Molecular and Cellular Cardiology·T L Vanden HoekL B Becker

❮ Previous
Next ❯

Citations

Nov 26, 2008·Bulletin of Experimental Biology and Medicine·L B DudnikM A Pokrovskaya
Jan 19, 2010·Chinese Journal of Integrative Medicine·Feng Qin, Xi Huang
Nov 26, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sevgi Yardim-AkaydinBolkan Simşek
Oct 5, 2013·European Journal of Medicinal Chemistry·Sukanya PandetiNarender Tadigoppula
Apr 27, 2005·Life Sciences·Jian SunYi Zhun Zhu
Mar 20, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jun RenHolly M Brown-Borg
Jan 1, 2010·Journal of Medicinal Food·Andriana C KalioraVaios T Karathanos
Jul 15, 2009·Clinical and Experimental Pharmacology & Physiology·Xin-Hua LiuYi-Zhun Zhu
Aug 29, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Ihsan IskesenHayrettin Sirin
Mar 14, 2002·Biochemical and Biophysical Research Communications·Zhuoxiao Cao, Yunbo Li
Apr 29, 2014·European Journal of Pharmacology·Oomaidurai SenthamizhselvanBoobalan Raja
Feb 1, 2013·Journal of Cardiovascular Pharmacology·Ingrid M BonillaCynthia A Carnes
Aug 18, 2006·Scandinavian Cardiovascular Journal : SCJ·Esra DenizHakki Engin Aksulu
Nov 28, 2015·International Journal of Molecular Sciences·Feng He, Li Zuo
Jan 31, 2012·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Mandar S JoshiJohn Anthony Bauer
Jul 5, 2011·European Journal of Medicinal Chemistry·Chunhua LiuYi Zhun Zhu
Oct 14, 2010·European Journal of Pharmacology·Li Xin WuYi Zhun Zhu
Feb 27, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·X H LiuY Z Zhu
Dec 8, 2009·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Ramalingam SivakumarChennam Srinivasulu Shyamaladevi
Oct 28, 2008·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·F QinZ-Y Zhu
Sep 6, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wei YangWen-Jun Wang
Apr 20, 2004·Biochemical and Biophysical Research Communications·Zhuoxiao Cao, Yunbo Li
Nov 30, 2005·Atherosclerosis·A C KalioraH Schmidt
Mar 30, 2007·Fundamental & Clinical Pharmacology·Ramón RodrigoRoberto Charles
Oct 16, 2008·Clinical and Experimental Hypertension : CHE·Engin SahnaOktay Burma
Jan 24, 2003·Expert Opinion on Therapeutic Targets·Hunter C Champion, Joshua M Hare
Jul 3, 2015·Oxidative Medicine and Cellular Longevity·Md Abu Taher SagorMd Ashraful Alam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.